Investigation of intestinal absorption of pyridinones in rat

Iranian Journal of Pharmaceutical Research

Volumn 3, Issue 4, 2004, Pages 201-207

  Taher, Masihalah ^a   Saghaie, Lotfollah ^a   Abrahilmi, Maryam ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

1.2 dimethyl 3 hydroxypyridin 4 one; Everted Gut Sac; Intestinal absorption; Partition coefficient

Indexed keywords

EID: 79952020347     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: 10.22037/IJPR.2010.602     Document Type: Article

References (14)

1. Weatherall D J and Clegg J B. The Thalassaemia Syndromes. 3rd ed. Blackwell Scientific Publications, Oxford (1981) 152-155
2. Halliwell B and Gutteridge J M C. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. (1986) 219: 1-14
3. Hershko C, Konijn A M and Link G. Iron chelators for thalassaemia. Br. J. Haematol. (1998) 101: 399-406
4. Tilbrook G S and Hider R C. Iron Chelators for Clinical Use. In: Sigel A and Sigel H (eds.) Metal Ions in Biological Systems. Vol. 35: Iron transport and storage in micro organisms, plants and animals. Marcel Dekker, New York (1998) 691-730
5. Singh S, Epemolu O, Dobbin P S, Tilbrook G S, Ellis B L, Damani L A and Hider R C. Urinary metabolic profiles in man and rat of 1,2-dimethyl and 1,2-diethyl substituted 3-hydroxypyridin-4-ones. Drug Metab. Dispos. (1992) 20: 256-261
6. Harris R L N. Potential wool growth inhibitors. Improved synthesis of mimosine and related 4(1H)-Pyridinones. Aust. J. Chem. (1976) 29: 1320-1334
7. Gardiner P E, Posick E, Bratter P and Kymast. The application of gel filtration, immunoephelometry and electro thermal atomic absorption spectrometry to the study distribution of copper, iron and zinc-bound constituents in human amniotic fluid. Clin. Chem. Acta (1982) 120: 103-117
8. Imafuku K, Takahashi and Matsumurg H. Substituent effects on 6-substituted 3-hydroxyl-1-methyl-4-pyridinones. Bull. Chem. Soc. Jpn. (1979) S2: 111-113
9. Norian S. The Synthesis of the Orally Drug Deferiprone for Treatment of Thalassaemia Patients. (Pharm. D. Thesis), School of Pharmacy, Isfahan University of Medical Sciences (1980) 63-68
10. Saghaie L, Hider R C and Mostafavi S. Comparison automated continuous flow method with shake-flask method in determining partition coefficients of bidentate hydroxypyridinone ligands. Daru (2003) 11: 38-48
11. Rai B L, Dehkordi L S, Jin Y, Liu Z D and Hider R C. Synthesis, Physicochemical properties and evaluation of N-substituted 2-alkyl-3-hydroxypyridinones. J. Med. Chem. (1998) 41: 3347-59
12. Liu Z D and Hider R C. Design of iron chelaters. Chem. Rev. (2002) 232: 151-17174
13. Hider R C. Potential protection from toxicity by oral iron chelators. Toxicol. Lett. (1995) 82/83. 961-967
14. Habgood M D, Liu Z D, Dehkordi L S, Khodr H H, Abbott J and Hider R C. Investigation into the Correlation between the Structure of Hydroxypyridinones and Blood-Brain Barrier Permeability. Biochem. Pharmacol. (1999) 57: 1305-1310